BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Park BJ, Byun JH, Jin YH, Won HJ, Shin YM, Kim KW, Park SJ, Kim PN. CT-guided radiofrequency ablation for hepatocellular carcinomas that were undetectable at US: therapeutic effectiveness and safety. J Vasc Interv Radiol. 2009;20:490-499. [PMID: 19328427 DOI: 10.1016/j.jvir.2009.01.004] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Tsapaki V, Tsalafoutas I, Triantopoulou C, Kolliakou E, Maniatis P, Papailiou J. Radiation dose in repeated CT guided radiofrequency ablations. Physica Medica 2014;30:128-31. [DOI: 10.1016/j.ejmp.2013.04.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
2 Mauri G, Cova L, De Beni S, Ierace T, Tondolo T, Cerri A, Goldberg SN, Solbiati L. Real-time US-CT/MRI image fusion for guidance of thermal ablation of liver tumors undetectable with US: results in 295 cases. Cardiovasc Intervent Radiol. 2015;38:143-151. [PMID: 24806953 DOI: 10.1007/s00270-014-0897-y] [Cited by in Crossref: 119] [Cited by in F6Publishing: 106] [Article Influence: 14.9] [Reference Citation Analysis]
3 Cathomas M, Mertineit N, Kim-Fuchs C, Lachenmayer A, Maurer MH. Value of MRI/CT Image Fusion for Targeting "invisible" Lesions in Stereotactic Microwave Ablation (SMWA) of Malignant Liver Lesions: A Retrospective Analysis. Cardiovasc Intervent Radiol 2020;43:1505-14. [PMID: 32642989 DOI: 10.1007/s00270-020-02565-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Neshat H, Cool DW, Barker K, Gardi L, Kakani N, Fenster A. A 3D ultrasound scanning system for image guided liver interventions: A 3D ultrasound system for image-guided liver interventions. Med Phys 2013;40:112903. [DOI: 10.1118/1.4824326] [Cited by in Crossref: 33] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
5 Ishizaka H, Awata S, Arai H, Hirasawa S, Shimizu A. CT-guided radiofrequency liver tumour ablation: use of a two-step coaxial system with a fine guide needle wire unit for high-risk cases. Br J Radiol 2010;83:1077-9. [PMID: 21088092 DOI: 10.1259/bjr/21804442] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
6 Vo Chieu VD, Werncke T, Hensen B, Wacker F, Ringe KI. CT-Guided Microwave Ablation of Liver Tumors in Anatomically Challenging Locations. Cardiovasc Intervent Radiol 2018;41:1520-9. [DOI: 10.1007/s00270-018-2007-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
7 Iguchi T, Inoue D, Yabushita K, Sakaguchi K, Tatsukawa M, Sasaki H, Kanazawa S. Effect of CT fluoroscopy-guided transpulmonary radiofrequency ablation of liver tumours on the lung. Br J Radiol. 2012;85:e373-e377. [PMID: 22374277 DOI: 10.1259/bjr/34646739] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
8 Kim J, Yoon C, Seong N, Jeong S, Kim J. Fluoroscopy-guided radiofrequency ablation for small hepatocellular carcinoma: a retrospective comparison with ultrasound-guided ablation. Clinical Radiology 2015;70:1009-15. [DOI: 10.1016/j.crad.2015.05.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
9 Samimi K, White JK, Brace CL, Varghese T. Monitoring Microwave Ablation of Ex Vivo Bovine Liver Using Ultrasonic Attenuation Imaging. Ultrasound Med Biol 2017;43:1441-51. [PMID: 28454843 DOI: 10.1016/j.ultrasmedbio.2017.03.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
10 Wu J, Chen P, Xie YG, Gong NM, Sun LL, Sun CF. Comparison of the effectiveness and safety of ultrasound- and CT-guided percutaneous radiofrequency ablation of non-operation hepatocellular carcinoma. Pathol Oncol Res 2015;21:637-42. [PMID: 25466642 DOI: 10.1007/s12253-014-9868-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
11 Huo J, Aloia TA, Xu Y, Chung TH, Sheu T, Tina Shih YC. Comparative Effectiveness of Computed Tomography- Versus Ultrasound-Guided Percutaneous Radiofrequency Ablation Among Medicare Patients 65 Years of Age or Older With Hepatocellular Carcinoma. Value Health 2019;22:284-92. [PMID: 30832966 DOI: 10.1016/j.jval.2018.10.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Kamei S, Matsuda J, Hagihara M, Kitagawa A, Izumi Y, Katsuda E, Oshima Y, Ikeda S, Kimura J, Ota T. Oblique approach for CT-guided liver radiofrequency ablation using multiplanar reformation images in hepatocellular carcinoma. Jpn J Radiol. 2012;30:533-539. [PMID: 22528338 DOI: 10.1007/s11604-012-0074-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
13 Degrauwe N, Hocquelet A, Digklia A, Schaefer N, Denys A, Duran R. Theranostics in Interventional Oncology: Versatile Carriers for Diagnosis and Targeted Image-Guided Minimally Invasive Procedures. Front Pharmacol 2019;10:450. [PMID: 31143114 DOI: 10.3389/fphar.2019.00450] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
14 Nishigaki Y, Tomita E, Hayashi H, Suzuki Y, Iritani S, Kato T, Yamada T. Efficacy and safety of radiofrequency ablation for hepatocellular carcinoma in the caudate lobe of the liver. Hepatol Res 2013;43:467-74. [PMID: 23072582 DOI: 10.1111/j.1872-034X.2012.01095.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
15 Yamagami T, Yoshimatsu R, Matsushima S, Tanaka O, Miura H, Nishimura T. Diaphragmatic hernia after radiofrequency ablation for hepatocellular carcinoma. Cardiovasc Intervent Radiol. 2011;34 Suppl 2:S175-S177. [PMID: 20237779 DOI: 10.1007/s00270-010-9832-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
16 Lee MW, Lim HK. Management of sub-centimeter recurrent hepatocellular carcinoma after curative treatment: Current status and future. World J Gastroenterol 2018; 24(46): 5215-5222 [PMID: 30581270 DOI: 10.3748/wjg.v24.i46.5215] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
17 Kim GM, Won JY, Kim MD, Park SI, Lee do Y, Shin W, Shin M, Han KH, Kim do Y, Kim SU. Cryoablation of Hepatocellular Carcinoma with High-Risk for Percutaneous Ablation: Safety and Efficacy. Cardiovasc Intervent Radiol. 2016;39:1447-1454. [PMID: 27256103 DOI: 10.1007/s00270-016-1384-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
18 Hakime A, Deschamps F, De Carvalho EG, Teriitehau C, Auperin A, De Baere T. Clinical evaluation of spatial accuracy of a fusion imaging technique combining previously acquired computed tomography and real-time ultrasound for imaging of liver metastases. Cardiovasc Intervent Radiol. 2011;34:338-344. [PMID: 20845039 DOI: 10.1007/s00270-010-9979-7] [Cited by in Crossref: 49] [Cited by in F6Publishing: 37] [Article Influence: 4.1] [Reference Citation Analysis]
19 Hyun D, Cho SK, Shin SW, Park KB, Lee SY, Park HS, Do YS. Combined transarterial chemoembolization and radiofrequency ablation for small treatment-naïve hepatocellular carcinoma infeasible for ultrasound-guided radiofrequency ablation: long-term outcomes. Acta Radiol 2018;59:773-81. [PMID: 29034691 DOI: 10.1177/0284185117735349] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
20 Elhawary H, Oguro S, Tuncali K, Morrison PR, Tatli S, Shyn PB, Silverman SG, Hata N. Multimodality non-rigid image registration for planning, targeting and monitoring during CT-guided percutaneous liver tumor cryoablation. Acad Radiol 2010;17:1334-44. [PMID: 20817574 DOI: 10.1016/j.acra.2010.06.004] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
21 Schullian P, Johnston E, Laimer G, Putzer D, Eberle G, Amann A, Effenberger M, Maglione M, Freund MC, Loizides A, Bale R. Frequency and risk factors for major complications after stereotactic radiofrequency ablation of liver tumors in 1235 ablation sessions: a 15-year experience. Eur Radiol 2021;31:3042-52. [PMID: 33125554 DOI: 10.1007/s00330-020-07409-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
22 Schullian P, Putzer D, Laimer G, Levy E, Bale R. Feasibility, safety, and long-term efficacy of stereotactic radiofrequency ablation for tumors adjacent to the diaphragm in the hepatic dome: a case-control study. Eur Radiol 2020;30:950-60. [PMID: 31489472 DOI: 10.1007/s00330-019-06399-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
23 Lee H, Yoon CJ, Seong NJ, Jeong SH, Kim JW. Comparison of Combined Therapy Using Conventional Chemoembolization and Radiofrequency Ablation Versus Conventional Chemoembolization for Ultrasound-Invisible Early-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Cancer Stage 0 or A). Korean J Radiol 2018;19:1130-9. [PMID: 30386144 DOI: 10.3348/kjr.2018.19.6.1130] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
24 Mitani H, Naito A, Chosa K, Kodama H, Sumida M, Moriya T, Awai K. Safety margin for CT- and US-guided radiofrequency ablation after TACE of HCC in the hepatic dome. Minim Invasive Ther Allied Technol 2021;:1-8. [PMID: 34726557 DOI: 10.1080/13645706.2021.1995436] [Reference Citation Analysis]
25 Tokue H, Tsushima Y, Ishizaka H, Nakazawa A. Use of a novel coaxial guide needle-wire (GNW) combination system for computed tomography guided radiofrequency tumor ablation. World J Surg Oncol 2011;9:127. [PMID: 21995771 DOI: 10.1186/1477-7819-9-127] [Reference Citation Analysis]
26 Takaki H, Yamakado K, Nakatsuka A, Yamada T, Uraki J, Kashima M, Yamanaka T, Shiraki K, Takei Y, Takeda K. Computed tomography fluoroscopy-guided radiofrequency ablation following intra-arterial iodized-oil injection for hepatocellular carcinomas invisible on ultrasonographic images. Int J Clin Oncol 2013;18:46-53. [DOI: 10.1007/s10147-011-0340-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
27 Qi H, Zhang H, Wan C, Xie L, Song Z, Fan W. CT-guided microwave ablation through the lungs for treating liver tumors near the diaphragm. Oncotarget 2017;8:79270-8. [PMID: 29108305 DOI: 10.18632/oncotarget.17422] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
28 Minami Y, Kudo M. Review of dynamic contrast-enhanced ultrasound guidance in ablation therapy for hepatocellular carcinoma. World J Gastroenterol 2011; 17(45): 4952-4959 [PMID: 22174544 DOI: 10.3748/wjg.v17.i45.4952] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
29 Howenstein MJ, Sato KT. Complications of radiofrequency ablation of hepatic, pulmonary, and renal neoplasms. Semin Intervent Radiol. 2010;27:285-295. [PMID: 22550368 DOI: 10.1055/s-0030-1261787] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
30 Arnolli MM, Buijze M, Franken M, de Jong KP, Brouwer DM, Broeders IAMJ. System for CT-guided needle placement in the thorax and abdomen: A design for clinical acceptability, applicability and usability. Int J Med Robot 2018;14. [PMID: 29205787 DOI: 10.1002/rcs.1877] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 3.2] [Reference Citation Analysis]
31 Brook OR, Mendiratta-Lala M, Brennan D, Siewert B, Faintuch S, Goldberg SN. Imaging findings after radiofrequency ablation of adrenal tumors. AJR Am J Roentgenol 2011;196:382-8. [PMID: 21257891 DOI: 10.2214/AJR.10.4680] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
32 Lee LH, Hwang JI, Cheng YC, Wu CY, Lee SW, Yang SS, Yeh HZ, Chang CS, Lee TY. Comparable Outcomes of Ultrasound versus Computed Tomography in the Guidance of Radiofrequency Ablation for Hepatocellular Carcinoma. PLoS One 2017;12:e0169655. [PMID: 28068369 DOI: 10.1371/journal.pone.0169655] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
33 Farouil G, Deschamps F, Hakime A, de Baere T. Coil-assisted RFA of poorly visible liver tumors: effectiveness and risk factors of local tumor progression. Cardiovasc Intervent Radiol 2014;37:716-22. [PMID: 23925920 DOI: 10.1007/s00270-013-0717-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Yang BS, Liu LX, Yuan M, Hou YB, Li QT, Zhou S, Shi YX, Gao BL. Multiple imaging modality-guided radiofrequency ablation combined with transarterial chemoembolization for hepatocellular carcinoma in special locations. Diagn Interv Radiol 2020;26:131-9. [PMID: 32071022 DOI: 10.5152/dir.2019.18540] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Floridi C, Radaelli A, Abi-Jaoudeh N, Grass M, Lin M, Chiaradia M, Geschwind JF, Kobeiter H, Squillaci E, Maleux G. C-arm cone-beam computed tomography in interventional oncology: technical aspects and clinical applications. Radiol Med. 2014;119:521-532. [PMID: 25012472 DOI: 10.1007/s11547-014-0429-5] [Cited by in Crossref: 55] [Cited by in F6Publishing: 43] [Article Influence: 6.9] [Reference Citation Analysis]
36 Kato K, Abe H, Ika M, Yonezawa T, Sato Y, Hanawa N, Shimizu S, Endo S, Matsuo R, Tsubota A. C-Arm Cone Beam Computed Tomography Guidance for Radiofrequency Ablation in Hepatocellular Carcinoma. Oncology. 2017;92:142-152. [PMID: 28052301 DOI: 10.1159/000453665] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
37 Chen R, Zhang J, Kong D, Lou Q, Lu F. Fast calculation of 3D radiofrequency ablation zone based on a closed-form solution of heat conduction equation fitted by ex vivo measurements. Phys Med Biol 2021;66:055022. [PMID: 33503590 DOI: 10.1088/1361-6560/abe052] [Reference Citation Analysis]
38 Pandeya GD, Greuter MJ, Schmidt B, Flohr T, Oudkerk M. Assessment of thermal sensitivity of CT during heating of liver: an ex vivo study. Br J Radiol 2012;85:e661-5. [PMID: 22919016 DOI: 10.1259/bjr/23942179] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
39 Koh YH, Choi JI, Kim HB, Kim MJ. Computed tomographic-guided radiofrequency ablation of recurrent or residual hepatocellular carcinomas around retained iodized oil after transarterial chemoembolization. Korean J Radiol 2013;14:733-42. [PMID: 24043966 DOI: 10.3348/kjr.2013.14.5.733] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
40 Rubert N, Bharat S, DeWall RJ, Andreano A, Brace C, Jiang J, Sampson L, Varghese T. Electrode displacement strain imaging of thermally-ablated liver tissue in an in vivo animal model. Med Phys 2010;37:1075-82. [PMID: 20384243 DOI: 10.1118/1.3301603] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
41 Tsapaki V, Rehani M, Saini S. Radiation safety in abdominal computed tomography. Semin Ultrasound CT MR. 2010;31:29-38. [PMID: 20102693 DOI: 10.1053/j.sult.2009.09.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]